Publications
PUBLICATIONS
February 6, 2020
Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trial
Journal of the American Academy of Dermatology
January 17, 2020
A Multi-Center, Open-Label Extension Study to Assess the Long-term Safety/Tolerability and Pharmacokinetics, and Explore the Efficacy of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, 9 to 16 Years of Age, with Primary Axillary Hyperhidrosis
Poster Presentation at ODAC Dermatology, Aesthetic and Surgical Conference
October 17, 2019
A Multi-Center, Open-Label Study to Assess Pharmacokinetics (PK), Safety and Tolerability of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, ≥9 to <17 Years of Age, with Axillary Hyperhidrosis
Poster Presentation at Fall Clinical Dermatology Conference